Hook & thesis
TTM Technologies (TTMI) reported a blowout quarter on 10/23/2026 - revenue of $1.20 billion and non-GAAP EPS of $1.46 - yet the stock plunged more than 20% that same week. The disconnect is simple: investors cheered growth but are worried about stretched lead times, a spate of strategic acquisitions, and rising interest costs. That combination creates an asymmetric trade opportunity right now.
My thesis: TTMI is still fundamentally a growth company driven by AI/data-center demand and a rising defense backlog, and the market's knee-jerk reaction presents a mid-term swing entry for disciplined traders. But this is not a “buy-and-forget” setup - execution and supply-chain risk are real. Trade size accordingly.
What the company does and why the market should care
TTM Technologies manufactures printed circuit boards (PCBs), backplane assemblies, RF components, and value-added assemblies. The business is organized into Aerospace & Defense, Commercial, and RF & Specialty Components. The market should care because TTMI sits at the intersection of two durable end-market tailwinds: AI/data-center buildouts and defense spending. Management says AI-related demand lifted Data Center and Networking sales by 115% in the quarter, and a multi-billion-dollar defense backlog supports multi-year visibility into higher-margin work.
Recent performance and the drivers
Key reported numbers on 10/23/2026:
- Revenue: $1.20 billion in Q3 2026, +59.9% year-over-year.
- Non-GAAP EPS: $1.46, up 117.9% year-over-year.
- Adjusted EBITDA margin: ~20.1% reported by commentary.
- 2027 guidance: net sales of $6.5 - $6.75 billion and EPS guidance of $8.10 - $8.90.
- Planned capacity investment: $400 million for 2028 expansion to capture AI/data-center demand.
Those are strong operating signs: revenue and margin expansion concurrent with capital investments and targeted M&A (Epiq Solutions and MKS Inc.'s Ophir division) to broaden aerospace/defense capabilities. Management's 2027 top-line guidance implies continued high-single to double-digit growth from the current revenue base.
Valuation framing
Market snapshots put TTMI at a market cap of roughly $9.14 billion and an enterprise value near $9.61 billion. That implies:
- EV / Sales ~ 2.84x.
- EV / EBITDA ~ 19.7x.
- Reported P/E in the high 30s (data shows around ~34-39x depending on metric used).
Those multiples look elevated versus a broad manufacturing peer group but are more defensible if you treat TTMI as a high-growth, data-center-capex beneficiary with improving margins. The company is guiding to substantially higher EPS next year (management's $8.10 - $8.90), which would materially improve the forward P/E if realized. If the market starts to price in the 2027 numbers, the current pullback is a spot to buy growth at a discount to the prior run-up.
Technical and sentiment backdrop
Technicals are mixed-to-negative in the very near term: the 10-day SMA is $92.16, the 50-day SMA sits near $115, and the 52-week high is $223.83 with a 52-week low of $55.44. Momentum indicators show bearish tilt (RSI ~38, MACD histogram negative). Short interest and short-volume data indicate active short sellers: short interest rose to 4.97M on 10/15 with days-to-cover near 1.69, and multiple large-volume days showed heavy short activity. That increases volatility risk but also the potential for squeezes if sentiment flips.
Trade plan - tactical, mid-term (45 trading days)
| Trade | Details |
|---|---|
| Direction | Long |
| Entry Price | $89.10 |
| Target Price | $135.00 |
| Stop Loss | $72.00 |
| Horizon | Mid term (45 trading days) - enough time for supply issues to be clarified and the market to re-rate forward guidance. |
| Risk level | Medium |
Why this entry and these levels?
Entry at $89.10 captures the post-earnings weakness while leaving room for a modest additional leg down. The $72 stop sits below recent swing support zones and well below the panic low earlier in the year, limiting downside while acknowledging that a material execution failure would re-price the name. The $135 target assumes mean reversion toward earlier technical levels and partial reappraisal of the 2027 revenue/EPS guidance; it values TTMI at a still-stretched multiple but reasonable if growth persists and EBITDA margins hold above ~18-20%.
Catalysts that could drive the trade
- Operational updates clarifying lead-time remediation and component flow - any sign that the 24-week lead times are shortening would materially reduce risk premium.
- Quarterly cadence - Q4 results or interim updates confirming that the data-center division recovers the 10% shortfall reported for the quarter.
- Defense order flow - execution or bookings that convert the reported ~$2 billion defense backlog into visible revenue helps margins and de-risks acquisitions.
- Integration milestones for recent acquisitions and visibility on cost synergies - proof that acquisitions are accretive would lift investor confidence.
Risks and counterarguments
There are multiple legitimate reasons the market sold off hard and for caution to persist:
- Supply-chain execution risk. Management cited supply bottlenecks that extended lead times to ~24 weeks and caused the data-center division to miss targets by ~10%. If lead times persist, revenue growth could be lumpy and margins pressured.
- Rising interest costs from M&A. Recent acquisitions have increased interest expense by roughly $20 million per quarter, eroding free cash flow near-term. The company posted a small negative free cash flow in the ratios, which could worsen if capex and acquisition costs continue to ramp.
- High valuation vs. cyclicality. Even with 2027 guidance, EV/EBITDA ~19.7x and EV/Sales ~2.84x assume continued high growth and margin stability. A slowdown in AI capex or data-center demand would quickly compress multiples.
- Market sentiment and technical risk. Heavy short activity and bearish technical indicators increase volatility and the chance of further downside before recovery.
- Integration risk for defense-focused acquisitions. Buying Epiq Solutions and parts of MKS Ophir can be accretive long-term but introduce integration complexity and potential cost overruns.
Counterargument (why not buy): If you believe lead-time issues will persist into 2027 and that the added interest burden from acquisitions will materially erode margins and free cash flow, then TTMI is more of a structural-risk trade than a simple dip-to-buy. Under that view, the stock may revisit much lower levels as the market de-rates the growth multiple.
What would change my mind
I would become more bullish (and enlarge exposure) if TTMI reports a clear improvement in lead times within the next two quarters, shows sequential margin expansion, and demonstrates that the $400 million capacity plan is on track with predictable timing. Conversely, I would step back or flip bearish if supply-chain issues persist beyond Q2 2027, free cash flow turns deeply negative as debt service rises, or if defense integration costs materially miss expectations.
Position sizing and execution notes
This is a tactical swing trade, not a full conviction long for every portfolio. Given the volatility and execution risk, consider allocating a limited portion of risk capital (e.g., 1-2% of portfolio value) and using the stop cleanly at $72.00. If you prefer a more conservative approach, wait for a confirmed technical base or a dip below $80 followed by an on-balance-volume uplift before entering.
Bottom line
TTM Technologies is a classic growth-with-pain situation: strong end-market demand and aggressive capacity/bolt-on acquisition strategy, but near-term execution and funding frictions have created a window of opportunity for a disciplined swing trade. Entry at $89.10 with a stop at $72.00 and a target of $135.00 balances upside from re-rating and growth capture against the material operational risks that prompted the recent sell-off. Keep position sizes controlled and treat the trade as conditional on improving supply indicators and acquisition integration progress.
Key points
- Q3 revenue $1.20B and non-GAAP EPS $1.46 (10/23/2026) show robust growth from AI/data-center demand.
- Management guides 2027 revenue $6.5B - $6.75B and EPS $8.10 - $8.90, implying substantial upside if realized.
- Valuation (EV/EBITDA ~19.7x) is elevated but can be justified if growth and margins hold.
- Primary risks: supply-chain lead times (~24 weeks), higher interest expense from M&A (~$20M/quarter), and integration execution for defense deals.